Related Experiment Video
Updated: Jun 14, 2026
Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
[Expression of nuclear autoantigenic sperm protein in platinum resistance ovarian cancer cell clones]
1Department of Obstetrics and Gynecology, Affiliated Yuquan Hospital of Tsinghua University, Beijing 100049, China.
Objective:
To study the expression of NASP in platinum resistance ovarian cancer cell clones (C0C1/DDP).
Methods:
The proteins of C0C1 and C0C1/DDP were separated by highly sensitive two-dimensional differential gel electrophoresis (2-D DIGE) coupled with matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF-MS) to identify the proteins differentially expressed in cisplatin sensitive and cisplatin resistance cell lines.
Results:
The investigators found a group of the distinct expressed proteins between C0C1 and C0C1/DDP. Among them, NASP was one of the down-regulated proteins by 21% (Student's t-test; P = 0.01).
Conclusion:
The identification of NASP in C0C1/DDP has laid a foundation for future in-depth researches into the mechanisms of ovarian cancer platinum resistance.
Insights
Nuclear autoantigenic sperm protein (NASP) was found to be downregulated in platinum-resistant ovarian cancer cells. This finding provides a basis for further research into ovarian cancer platinum resistance mechanisms.
Area of Science:
- Proteomics
- Molecular Biology
- Cancer Research
Context:
- Ovarian cancer is a leading cause of cancer-related deaths in women.
- Platinum-based chemotherapy is a cornerstone of ovarian cancer treatment.
- Acquired platinum resistance remains a major clinical challenge.
Purpose:
- To investigate the differential protein expression in cisplatin-sensitive (C0C1) and cisplatin-resistant (C0C1/DDP) ovarian cancer cell lines.
- To identify specific proteins involved in the development of platinum resistance in ovarian cancer.
Summary:
- Two-dimensional differential gel electrophoresis (2-D DIGE) coupled with MALDI-TOF-MS was employed to compare protein profiles of C0C1 and C0C1/DDP cells.
- A distinct set of proteins was identified between the sensitive and resistant cell lines.
- Nuclear autoantigenic sperm protein (NASP) was found to be significantly downregulated by 21% in the platinum-resistant C0C1/DDP cells compared to C0C1 cells (P = 0.01).
Impact:
- The identification and quantification of NASP downregulation in platinum-resistant ovarian cancer cells offer a novel biomarker candidate.
- This study lays the groundwork for future investigations into the specific role of NASP in mediating ovarian cancer platinum resistance.
- Understanding NASP's function may lead to the development of new therapeutic strategies to overcome platinum resistance.
